Announcement on Stock Repurchase, Shareholding Increase and Loan Extension
The abstract is for reference only. Please refer to the full text of the announcement on the very day.
Link of Full Text for Reference: View Attachment
Announcement on Stock Repurchase, Shareholding Increase and Loan Extension
Filed with SSE ·
6ix hasn’t read this filing yet.
Beijing Sun-Novo Pharmaceutical Research Co. Ltd. on 6ix
Earlier from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Deferring the Reply to the "Inquiry Letter Regarding the Review of Beijing Sun-Novo Pharmaceutical Research Co.,Ltd.’s Share Issuance and Convertible Bond Issuance for Asset Acquisition and Raising of Supporting Funds, and Related Party Transaction"
- Announcement on Signing the Technology Development Agreement for STC008 Injection
- Announcement on Voluntary Disclosure of Co-Establishment of a Joint Laboratory
- Announcement on Resolutions of the 5th Extraordinary General Meeting in 2025
- Announcement on Progress in Cancellation of Sub-subsidiary Nanjing Novostream Pharmaceutical Technology Co., Ltd. and Related Party Transactions
Later from Beijing Sun-Novo Pharmaceutical Research
- Announcement on Litigation Results of the Company
- Announcement on Voluntary Disclosure on the Acceptance of Clinical Trial Application for ABA001 Injection
- Announcement on Terminating the Issuance of Shares and Convertible Corporate Bonds to Purchase Assets and Raising Supporting Funds and Related Party Transactions, and the Withdrawal of Application Documents
- Announcement on Progress in Litigation Involved by the Company
- Announcement on Preliminary Earnings Estimate for 2025
Follow Beijing Sun-Novo Pharmaceutical Research into a list and get an email when it puts out news.
Follow Beijing Sun-Novo Pharmaceutical Research